Job Opportunities

NSI will advertise available jobs of relevance to our members upon request.


Logo bedrift

PhD position is available for a period of three (3) years at the University of Bergen, Faculty of Medicine, Department of Clinical Science.

The position is part of a 5-year European Research Council (ERC) project “Oral Bacteria as determinants for Respiratory Health (BRuSH)” awarded to Randi J Bertelsen.

The position is in collaboration with Professor Vivi Schlünssen at Aarhus University, Denmark, who will be co-supervisor for the PhD-candidate. Much of the laboratory data that will make up the basis for this PhD-project will be performed in Aarhus. It is therefore expected that the successful PhD-candidate will work in Aarhus for at least six (6) months of the project period. It is also possible that the PhD-candidate will take part in experimental models with project partners at Borstel Research Center in Germany.

Click here for more information.


University of Oslo – PhD position in Computational Immunology 

 

 

Open PhD position co-supervised by Ludvig Sollid and Greiff lab.

Application portal: https://www.jobbnorge.no/en/available-jobs/job/164579/phd-research-fellowship-in-computational-immunology

Tweet: https://twitter.com/victorgreiff/status/1093432827960541184

The candidate will develop and employ a variety of (deep) machine learning techniques, phylogenetic modeling as well as probabilistic Bayesian modelling to quantitatively characterize and predict pathogen recognition by the immune system and specifically in an autoimmune setting (celiac disease).

The candidate will also develop a software framework for fast and reliable processing of single-cell and proteomics immune cellomics data. The candidate will be expected to closely collaborate with machine learning experts, computational and experimental immunologists as well as clinicians.

Application deadline: 27 Feb 2019


Post-doctoral Fellow position in T cell biology/cancer immunotherapy

Related image

Cancer immunotherapy has experienced major breakthroughs over the last decade with the discoveries that the patient’s own cytotoxic T cells possess the ability to react against cancer cells and that unleash of immunosuppressive signals by blocking antibodies can lead to impressive clinical outcome. However, many cancer patients do not respond to immunotherapy. One possible reason is that T cells in the tumor are suppressed by other known or yet unknown components in the tumor microenvironment.

The project will be based on in vitro (human) and in vivo mouse studies of T cells using several of the following methods: flow cytometry, xCelligence, Seahorse/metabolic studies, gene silencing by siRNA, real-time qPCR, Western blotting, mRNA transfection and/or viral transduction of T cells, co-culture studies, and FACS sorting of cells for downstream functional and molecular analyses.

Click here for more information.


Post-doctoral Fellow position in Tumour Immunology/Osteoimmunology

Centre of Molecular Inflammation Research (SFF-CEMIR)

A post-doctoral research position is available in the lab of Prof. Therese Standal, a group leader at CEMIR.

The project is focused on the crosstalk between malignant plasma cells, T-cells and bone cells, and how infection and inflammation modulate this interplay. The work will be a combination of cell biological and biochemical work to decipher molecular mechanisms and in vivo experiments utilizing different mouse models of multiple myeloma.

The period of employment for the position is 2 years from March 1st 2019.

Click here for more information.